Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway

Fig. 3

Diallyl thiosulfinate and dexamethasone (DATS+Dex) cotreatment treatment promoted apoptosis of multiple myeloma (MM) side population (SP) cells and arrested their cell cycle. a and b Representative image of apoptosis and cell cycle of MM SP cells detected using flow cytometry analysis 48 h after treatment. Bar represents c apoptosis and d cell cycle distribution of MM SP cells. **P < 0.01 and ***P < 0.001 vs normal group, &&P < 0.01 and &&&P < 0.001 vs DATS group, and ###P < 0.001 vs Dex group

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us